Strategic collaboration extends TOOsonix’s reach into Poland, addressing skin diseases for a population of over 37 million.
TOOsonix, a manufacturer of advanced dermatological therapy devices, has announced a strategic partnership with Consultronix, a prominent distributor of cutting-edge medical devices in Poland. The collaboration will introduce TOOsonix’s state-of-the-art focused ultrasound skin therapy to the Polish market, providing healthcare professionals with a new innovative solution for treating skin diseases.
TOOsonix’s MDR CE-marked dermatological therapy addresses a wide range of age-related skin diseases, including very common basal cell carcinoma, actinic keratosis, and seborrheic keratosis. Treatments are fast, non-invasive, without need for anesthesia or post treatment, and have higher efficacy and better aesthetic outcome than traditional procedures.
Health Technology Insights: Alpine ENT Expands CareCloud Partnership to Boost Patient Experience
With approximately 20% of Poland’s population aged 65 and over, this partnership aims to improve care for this growing demographic affected by skin diseases. Leveraging Consultronix’s expertise and extensive network in hospitals and private clinics, the collaboration seeks to make these advanced therapies accessible to patients across the country.
“We are thrilled to partner with Consultronix to expand our presence in Central Europe,” said Torsten Bove and Tomasz Zawada, founders of TOOsonix. “Consultronix’s deep understanding of the Polish market and commitment to quality make them an ideal partner. Together, we aim to enhance patient outcomes by offering innovative dermatological solutions.”
Health Technology Insights: Curve Dental Introduces AI-Assisted Notations Powered by Bola AI
Consultronix has extensive experience in introducing advanced medical technologies to Poland. Their established relationships with dermatology clinics and hospitals will ensure a successful rollout of TOOsonix’s products.
“We are proud to collaborate with TOOsonix,” said Piotr Smolarski, CEO of Consultronix. “Their groundbreaking dermatological therapies align perfectly with our mission to equip Polish healthcare professionals with the best tools for addressing evolving patient needs.”
This partnership marks another milestone in TOOsonix’s international expansion strategy, reinforcing its commitment to making cutting-edge dermatological therapies available across Europe.
Health Technology Insights: Viseon Inc. Debuts Hubble AV System in Neurosurgery
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
